BRPI0412093A - formulação da barreira, uso de uma formulação, método para o tratamento e/ou profilaxia de infecção, e, método para a fabricação de uma formulação - Google Patents

formulação da barreira, uso de uma formulação, método para o tratamento e/ou profilaxia de infecção, e, método para a fabricação de uma formulação

Info

Publication number
BRPI0412093A
BRPI0412093A BRPI0412093-0A BRPI0412093A BRPI0412093A BR PI0412093 A BRPI0412093 A BR PI0412093A BR PI0412093 A BRPI0412093 A BR PI0412093A BR PI0412093 A BRPI0412093 A BR PI0412093A
Authority
BR
Brazil
Prior art keywords
formulation
treating
manufacturing
barrier
infection prophylaxis
Prior art date
Application number
BRPI0412093-0A
Other languages
English (en)
Inventor
Brian Bennett
Original Assignee
Hygieia Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0315430A external-priority patent/GB0315430D0/en
Priority claimed from GB0315726A external-priority patent/GB0315726D0/en
Application filed by Hygieia Healthcare Ltd filed Critical Hygieia Healthcare Ltd
Publication of BRPI0412093A publication Critical patent/BRPI0412093A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Cosmetics (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Paints Or Removers (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)

Abstract

"FORMULAçãO DE BARREIRA, USO DE UMA FORMULAçãO, MéTODO PARA O TRATAMENTO E/OU PROFILAXIA DE INFECçãO, E, MéTODO PARA A FABRICAçãO DE UMA FORMULAçãO". A presente invenção provê uma formulação de barreira melhorada que é utilizável em várias aplicações, e um método para sua fabricação. A formulação compreende uma emulsão tendo, pelo menos, uma fase óleo e uma fase aquosa em que a fase óleo compreende um composto de silicone, em que a viscosidade da formulação é de 20.000 cps ou menos.
BRPI0412093-0A 2003-07-01 2004-07-01 formulação da barreira, uso de uma formulação, método para o tratamento e/ou profilaxia de infecção, e, método para a fabricação de uma formulação BRPI0412093A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0315430A GB0315430D0 (en) 2003-07-01 2003-07-01 Improvement in or relating to organic material
GB0315726A GB0315726D0 (en) 2003-07-04 2003-07-04 Improvements in or relating to organic material
PCT/GB2004/002845 WO2005002537A2 (en) 2003-07-01 2004-07-01 Barrier formulation comprising a silicone based emulsion

Publications (1)

Publication Number Publication Date
BRPI0412093A true BRPI0412093A (pt) 2006-09-05

Family

ID=32852424

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0412093-0A BRPI0412093A (pt) 2003-07-01 2004-07-01 formulação da barreira, uso de uma formulação, método para o tratamento e/ou profilaxia de infecção, e, método para a fabricação de uma formulação

Country Status (16)

Country Link
US (1) US20060246026A1 (pt)
EP (1) EP1638516B1 (pt)
JP (1) JP2007526883A (pt)
AT (1) ATE460206T1 (pt)
AU (1) AU2004253341B2 (pt)
BR (1) BRPI0412093A (pt)
CA (1) CA2530157A1 (pt)
DE (1) DE602004025929D1 (pt)
EA (1) EA009549B1 (pt)
ES (1) ES2345199T3 (pt)
GB (1) GB2403410B (pt)
HK (1) HK1074382A1 (pt)
IL (1) IL172731A (pt)
NZ (1) NZ579455A (pt)
PT (1) PT1638516E (pt)
WO (1) WO2005002537A2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006007549A1 (de) * 2006-02-16 2007-08-30 Lanxess Deutschland Gmbh Öl-in-Wasser-Formulierung zur Arthropoden- und Plathelminthen-Abwehr
DE102006007546A1 (de) * 2006-02-16 2007-08-30 Saltigo Gmbh Wasser-in-Öl-Formulierung zur Arthropoden-und Plathelminthen-Abwehr
GB2471135A (en) * 2009-06-19 2010-12-22 H D S Ltd Hair dye composition and use in reducing contact allergy
EP3062769B1 (en) 2013-10-31 2018-12-26 L'Oréal Composition in form of an emulsion
CA3020157C (en) 2016-04-04 2024-01-16 Drug Delivery Solutions Limited Topical composition comprising tacrolimus
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate
GB2572642B (en) * 2018-04-06 2021-03-31 Pellis Care Ltd Treatment of diabetic foot ulcers

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE530917A (pt) * 1953-08-04
US4054670A (en) * 1972-02-04 1977-10-18 Growth Products, Inc. Skin-treating composition containing polysiloxane fluids
US4431632A (en) * 1982-05-25 1984-02-14 Carson Chemicals, Inc. Interfacial composition
DE3640177A1 (de) * 1986-11-25 1988-05-26 Bayer Ag Hautschuetzende bzw. hautpflegende zusammensetzung
JP2622980B2 (ja) * 1987-02-06 1997-06-25 レブロン・コンシューマー・プロダクツ・コーポレーション 顔料を含有する水中油型エマルションから成る化粧用組成物
JP2657504B2 (ja) * 1988-01-12 1997-09-24 株式会社資生堂 油中水型乳化組成物
US5126136A (en) * 1988-08-05 1992-06-30 Merat Pierre H Skin protection lotion
GB9010525D0 (en) * 1990-05-10 1990-07-04 Unilever Plc Cosmetic composition
EP0485012B1 (en) * 1990-11-08 1996-02-07 The Procter & Gamble Company Liquid antiperspirant composition
US5208013A (en) * 1991-06-03 1993-05-04 Olympus International, Inc. Composition for skin care and protection
US5254331A (en) * 1991-09-12 1993-10-19 Chanel, Inc. Skin cream composition
FR2684551B1 (fr) * 1991-12-05 1995-04-21 Oreal Huile cosmetique filtrante contenant une silicone filtre et un melange d'une silicone volatile et d'une huile de silicone ou d'une gomme de silicone et emulsion cosmetique filtrante contenant une telle huile.
WO1994013257A1 (en) * 1992-12-16 1994-06-23 Creative Products Resource Associates, Ltd. Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder
US5368844A (en) * 1992-12-16 1994-11-29 Colgate Palmolive Company Antiplaque, antigingivitis, anticaries oral composition
US5443760A (en) * 1993-06-03 1995-08-22 Dow Corning Corporation Silicone containing oil-in-water emulsions
WO1995026715A2 (en) * 1994-03-30 1995-10-12 Dumex-Alpharma A/S Use of fatty acid esters as bioadhesive substances
US5648083A (en) * 1995-02-10 1997-07-15 The Procter & Gamble Company Personal care compositions and wipe products containing the compositions
US6503952B2 (en) * 1995-11-13 2003-01-07 The Trustees Of Columbia University In The City Of New York Triple antimicrobial composition
US5869061A (en) * 1996-06-04 1999-02-09 Brugh; Bettie Sue Protective hand lotion of aloe vera gel and vitamin E gel
US5961958A (en) * 1996-07-16 1999-10-05 Four Star Partners Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth
FR2776514B1 (fr) * 1998-03-26 2001-03-09 Oreal Emulsion e/h, composition comprenant une telle emulsion et utilisation en cosmetique, pharmacie ou hygiene
US6649175B1 (en) * 1998-05-04 2003-11-18 Schering-Plough Healthcare Products, Inc. Skin barrier composition
US6180577B1 (en) * 1998-06-01 2001-01-30 Colgate-Palmolive Company Anti-germ attachment—composition
US6387382B1 (en) * 1998-11-23 2002-05-14 Axiom Laboratories, Inc. Water-proof, respirable, skin barrier composition
US6039935A (en) * 1998-12-30 2000-03-21 Elizabeth Arden Company, Division Of Conopco, Inc. Sunscreen compositions
US6187327B1 (en) * 1999-05-19 2001-02-13 Kevin Stack Antimicrobial sanitizing lotion with skin protection properties
DE19924276A1 (de) * 1999-05-27 2000-11-30 Beiersdorf Ag Zubereitungen vom Emulsionstyp W/O mit erhöhtem Wassergehalt, enthaltend ferner ein oder mehrere Alkylmethiconcopolyole und/oder Alky-Dimethiconcopolyole sowie gegebenenfals kationische Polymere
US6107261A (en) * 1999-06-23 2000-08-22 The Dial Corporation Compositions containing a high percent saturation concentration of antibacterial agent
DE19938757A1 (de) * 1999-08-16 2001-02-22 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen vom Typ Öl-in-Wasser
AU2001249365A1 (en) * 2000-04-04 2001-10-15 Becton, Dickinson And Company Foamable antimicrobial formulation
DE10022077A1 (de) * 2000-05-06 2001-11-08 Henkel Kgaa Kosmetisches Mittel enthaltend 2-Furanonderivate
JP4341871B2 (ja) * 2000-05-31 2009-10-14 信越化学工業株式会社 シリコーン重合物及びシリコーン組成物並びにそれを用いた化粧料
AU2001278487A1 (en) * 2000-08-07 2002-02-18 Waterfield, Philip Christopher Oral composition
DE10044313A1 (de) * 2000-09-07 2002-03-21 Beiersdorf Ag Lipidarme kosmetische und dermatologische Zubereitungen in Form von O/W-Emulsionen mit einem Gehalt an Fettsäuren
WO2002078667A1 (en) * 2001-03-29 2002-10-10 The Dial Corporation Antibacterial compositions for skin care
DE10143962A1 (de) * 2001-09-07 2003-03-27 Basf Ag Kosmetische und dermatologische Zubereitungen in Form von O/W-Emulsionen, enthaltend ein aminosubstituiertes Hydroxybenzophenon
DE10143963A1 (de) * 2001-09-07 2003-03-27 Basf Ag Kosmetische und dermatologische Zubereitungen in Form von W/O-Emulsionen, enthaltend ein aminosubstituiertes Hydroxybenzophenon
US6846846B2 (en) * 2001-10-23 2005-01-25 The Trustees Of Columbia University In The City Of New York Gentle-acting skin disinfectants
US7745686B2 (en) * 2001-11-02 2010-06-29 Playtex Products, Inc. Catamenial device
US7163674B2 (en) * 2002-05-09 2007-01-16 The Procter & Gamble Company Personal care compositions comprising a dicarboxy functionalized polyorganosiloxane
US6932976B2 (en) * 2002-08-08 2005-08-23 Kimberly-Clark Worldwide, Inc. Enzyme blocking skin protectant cream

Also Published As

Publication number Publication date
GB2403410A (en) 2005-01-05
ES2345199T3 (es) 2010-09-17
PT1638516E (pt) 2010-06-17
EP1638516B1 (en) 2010-03-10
GB0414806D0 (en) 2004-08-04
GB2403410B (en) 2005-10-26
WO2005002537A2 (en) 2005-01-13
WO2005002537A3 (en) 2005-03-24
CA2530157A1 (en) 2005-01-13
JP2007526883A (ja) 2007-09-20
AU2004253341B2 (en) 2010-11-25
EP1638516A2 (en) 2006-03-29
EA009549B1 (ru) 2008-02-28
IL172731A0 (en) 2006-04-10
AU2004253341A1 (en) 2005-01-13
HK1074382A1 (en) 2005-11-11
DE602004025929D1 (de) 2010-04-22
EA200600139A1 (ru) 2006-08-25
ATE460206T1 (de) 2010-03-15
IL172731A (en) 2010-06-30
NZ579455A (en) 2011-03-31
US20060246026A1 (en) 2006-11-02

Similar Documents

Publication Publication Date Title
DE60113851D1 (de) Bakteriophage mit breitem wirtspektrum
BR0207332A (pt) Composição de fluido de fraturamento hidráulico, e, processo para gerar fissuras em uma formação subterrânea
AR028512A1 (es) Composiciones antimicrobianas acidas para el tratamiento de alimentos y superficies que contactan alimentos y metodos para la utilizacion de estas
WO2004006850A3 (en) 3, 10, AND 12a SUBSTITUTED TETRACYCLINE COMPOUNDS
BR0214992A (pt) Artigo microfibrilado hidrofìlico, e, método para preparar o mesmo
CR7849A (es) Agente para la prevencion o tratamiento de neuropatias
BR0116935A (pt) Composto de tetraciclina, método para tratar um estado responsivo à tetraciclina em um indivìduo, e, composição farmacêutica
BRPI0412029A (pt) formulações para microprojeções revestidas contendo contra-ìons não-voláteis
NO20052463L (no) Nye injiserbare depotpreparater
CY1114554T1 (el) Ινδαζολια, βενζοτριαζολια και ν-αναλογα αυτων ως αναστολεις p38 κινασης
IL172731A0 (en) Barrier formulation comprising a silicone based emulsion
WO2005009943A3 (en) Substituted tetracycline compounds
ATE263563T1 (de) Mittel gegen juckreiz
CY1105349T1 (el) Θειαζολυλ-αναστολεις τυροκινασεων της οικογενειας tec
WO2003057169A3 (en) 4-dedimethylamino tetracycline compounds
BRPI0517887A (pt) combinações de inibidores de jaks
BR0208627A (pt) Combinações antineoplásicas tal como rapamicina junto com gencitabina ou fluorouracila
BR0312479A (pt) Composição de tratamento dos cabelos e/ou couro cabeludo, método de tratamento de caspa e uso de óleo de manjericão
BR112014018029A8 (pt) Preparação cosmética e/ou dermatológica fluida à temperatura ambiente, à base de uma emulsão de água em óleo
BRPI0418384A (pt) composições farmacêuticas e métodos referentes à inibição de adesões fibrosas utilizando diversos agentes
MX2024006991A (es) Composiciones farmaceuticas inyectables y usos de las mismas.
DE60236580D1 (de) Demulgator für wässrige verrohrungsflüssigkeiten
BR0208038A (pt) Uso de um ou mais componentes saudáveis e método para a administração de um componente saudável.
CL2004001421A1 (es) Composicion farmaceutica que comprende un compuesto derivado de 1,4-dipiperidin-4-il-piperazina; y su uso para la prevencion y/o tratamiento del dolor.
WO2024039901A3 (en) Cdk2 degraders and uses thereof

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.

B15K Others concerning applications: alteration of classification

Ipc: A61K 8/06 (2006.01), A61K 8/34 (2006.01), A61K 8/8